Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP-690,550 vs Tacrolimus in De Novo Kidney Transplant
NCT00106639Phase 2Completed
- Sponsor
- Pfizer
- Start
- May 2005
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tofacitinib in kidney transplant rejection, sponsored by Pfizer. Started May 2005; status: completed.
02
Drugs
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00106639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00106639.